We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6361:TSEEbara Corporation Analysis

Data as of 2026-05-22 - not real-time

¥5,452.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Ebara Corp (6361.T) is trading at ¥5,452, just above its 20‑day SMA of ¥5,442 and comfortably over its 50‑day SMA of ¥5,054, indicating a short‑term bullish bias. However, the MACD is in a bearish configuration with the line well below the signal and a negative histogram, and the RSI sits at a neutral 53, suggesting limited momentum upside. The stock’s DCF‑derived fair value of roughly ¥3,118 is far below the market price, while its PE of 32.8 exceeds the industry average of 29.5, flagging a clear overvaluation despite a modest 2% upside/downside potential. Revenue growth of 51% is impressive, yet margins are thin (gross 26%, operating 7.4%) and EPS is projected to decline, while the company carries a high debt‑to‑equity of 39.5, adding balance‑sheet risk.
On the dividend side, a 1.31% yield with a 35% payout ratio appears sustainable given strong operating cash flow, supporting income‑focused investors. Volatility is elevated at 61% over the past 30 days and beta hovers around 1.1, reflecting sensitivity to market swings and heightened risk. The broader market sentiment is in “Extreme Greed” mode (Fear‑Greed Index 91), which may be inflating the price further. Overall, the stock presents a mixed picture: robust top‑line growth and dividend stability counterbalanced by overvaluation, thin profitability, and heightened market risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and limited upside potential
  • Current price significantly above DCF fair value
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong revenue growth and sustainable dividend
  • Stable operating cash flow supporting earnings
  • Elevated valuation but improving earnings trajectory

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified global footprint mitigating regional shocks
  • Potential for margin improvement and debt reduction
  • Attractive dividend yield with reasonable payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth51.20%
Profit Margin4.55%
P/E Ratio32.8
ROE9.57%
ROA4.18%
Debt/Equity39.55
P/B Ratio2.0
Op. Cash Flow¥63.2B
Free Cash Flow¥39.3B
Industry P/E29.5

Technical Analysis

TrendBullish
RSI53.5
Support¥4,870.00
Resistance¥6,073.00
MA 20¥5,442.10
MA 50¥5,053.90
MA 200¥4,229.59
MACDBearish
VolumeStable
Fear & Greed Index91.16

Valuation

Fair Value¥3,118.34
Target Price¥5,562.73
Upside/Downside2.03%
GradeOvervalued
TypeBlend
Dividend Yield1.31%

Risk Assessment

Beta1.10
Volatility61.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.